Patent Assignment
Reel/Frame 062158/0881
Assignment of Assignor's Interest
Recorded: 2022-12-20
Pages: 9
Assignors
CHU, KATHERINE
Executed: 2022-11-16
WADHWA, JYOTI
Executed: 2022-11-14
CARBOL, JASON
Executed: 2022-11-14
PHIASIVONGSA, PASIT
Executed: 2022-12-15
LANGRISH, CLAIRE
Executed: 2022-12-13
THOMAS, DOLCA
Executed: 2022-12-19
Assignee
PRINCIPIA BIOPHARMA INC.
220 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(3)
Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile
Patent:
11,583,533 →
Application:
17/143,384 →
Publication:
US 2021/0205313
PCT:
PCT/US2021/012507 ↗
Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile
Application:
62/958,616 →
Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile
Application:
63/003,536 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.